Evidence map›Paper›PMID 23690823›Full record

ReviewClinical & developmental immunology2013

Potential of immunoglobulin A to prevent allergic asthma.

Anouk K Gloudemans, Bart N Lambrecht, Hermelijn H Smits

Open access · goldAbstract readReview
In one paragraph

Review in Clinical & developmental immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Asthma-Associated Long TSLP Inhibits the Production of IgA.International journal of molecular sciences · 2021
    Article
  13. Article
  14. Viability Status-Dependent Effect ofFrontiers in immunology · 2021
    Article
  15. Article
  16. Review
  17. Relationship between serum IgA level and allergy/asthma.The Korean journal of internal medicine · 2017
    Article
  18. Immunoglobulin Glycosylation Effects in Allergy and Immunity.Current allergy and asthma reports · 2016
    Review
  19. Article
  20. Probiotics and pregnancy.Current diabetes reports · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anouk K GloudemansDepartment of Pulmonology, Erasmus Medical Center, Rotterdam, The Netherlands.
Bart N Lambrecht
Hermelijn H Smits
Leiden University Medical Center · NLErasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic asthma is characterized by bronchial hyperresponsiveness, a defective barrier function, and eosinophilic lower airway inflammation in response to allergens. The inflammation is dominated by Th2 cells and IgE molecules and supplemented with Th17 cells in severe asthma. In contrast, in healthy individuals, allergen-specific IgA and IgG4 molecules are found but no IgE, and their T cells fail to proliferate in response to allergens, probably because of the development of regulatory processes that actively suppress responses to allergens. The presence of allergen-specific secretory IgA has drawn little attention so far, although a few epidemiological studies point at a reverse association between IgA levels and the incidence of allergic airway disease. This review highlights the latest literature on the role of mucosal IgA in protection against allergic airway disease, the mechanisms described to induce secretory IgA, and the role of (mucosal) dendritic cells in this process. Finally, we discuss how this information can be used to translate into the development of new therapies for allergic diseases based on, or supplemented with, IgA boosting strategies.

Indexed as

AllergensAsthmaBronchial HyperreactivityCytokinesDendritic CellsHumansImmune ToleranceImmunoglobulin AImmunoglobulin EImmunoglobulin GImmunotherapyInflammationRespiratory MucosaTh17 CellsTh2 CellsAllergensCytokinesImmunoglobulin AImmunoglobulin EImmunoglobulin G

Identifiers

PMID23690823
PMCPMC3649226
OpenAlexW1972893222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.